The price target of AAL has been increased by analysts working at the Goldman Sachs Group from a sum of $11 to a sum of $20. This was published in a Tuesday research note. The rating set by the brokerage on the company currently is neutral. This price target indicates a negative annual growth rate of 20.54% from the previous close of the company.
The Stock Commentary of AAL
There have been quite a few research equities that have commented on AAL. Susquehanna Bancshares has been one of the first brokerages to increase the price target of the company from $8 to $10, with a rating of negative in a 14th January research report.
Cowen has also reduced the shares of the company from a rating of outperform to market perform in an 11th January research report. Deutsche Bank has increased the rating of the company from hold to buy, with a price target of $23 set in a 1st March research report. Stifel Nicolaus has also increased the price target of the company from $14 to $20, with a rating of hold in a 24th February research report.
Eleven of the investment analysts have already given the company a rating of sell, while seven others have issued it with a rating of hold. Currently, AAL has a sell rating with a $14.47 price target.
The stocks of AAL traded on Tuesday at $25.17. The year low of the firm is $8.25, while the year high has been set at $25.94. The market cap of the firm is $16.10 billion, with a -1.82 PE ratio. The moving average price of the company over a period of 50 days is $19.05, while the moving average price of the company over 200 days is $15.22.
